Karin Lilja
- Molecular Biology top 10%
- Cell Biology top 2%
- Cancer Research top 10%
- Surgery
- Genetics
- Co-authors
- Torvard C. LaurentAnna Engström‐LaurentUlla B.G. LaurentRolf K. ReedU. B. G. LaurentAnders TengbladTudorita TumbarRoss N. P. Cahill
- Topics
- Proteoglycans and glycosaminoglycans research (13 papers)Hair Growth and Disorders (4 papers)Glycosylation and Glycoproteins Research (3 papers)
- Cited by
- Cell BiologyCancer ResearchUrology
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsThe Journal of Experimental Medicine
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Karin Lilja
21 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 712
- Cell Biology 587
- Cancer Research 239
- Surgery 109
- Genetics 93
Countries citing papers authored by Karin Lilja
This map shows the geographic impact of Karin Lilja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Lilja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Lilja more than expected).
Fields of papers citing papers by Karin Lilja
This network shows the impact of papers produced by Karin Lilja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Lilja. The network helps show where Karin Lilja may publish in the future.
Co-authorship network of co-authors of Karin Lilja
This figure shows the co-authorship network connecting the top 25 collaborators of Karin Lilja. A scholar is included among the top collaborators of Karin Lilja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Lilja. Karin Lilja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | 237 | |
| 3 | 36 | |
| 4 | 32 | |
| 5 | 51 | |
| 6 | 20 | |
| 7 | 56 | |
| 8 | 30 | |
| 9 | 32 | |
| 10 | ICAM-1 is a cell-surface receptor for hyaluronan. | 2 |
| 11 | 6 | |
| 12 | 132 | |
| 13 | 8 | |
| 14 | 54 | |
| 15 | 52 | |
| 16 | 141 | |
| 17 | 16 | |
| 18 | 50 | |
| 19 | 205 | |
| 20 | 55 |
About Karin Lilja
Karin Lilja is a scholar working on Cell Biology, Urology and Otorhinolaryngology, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (13 papers), Hair Growth and Disorders (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Cell Biology (587 citations), Cancer Research (239 citations) and Urology (69 citations). Karin Lilja has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Torvard C. Laurent, Anna Engström‐Laurent, Ulla B.G. Laurent, Rolf K. Reed, U. B. G. Laurent, Anders Tengblad, Tudorita Tumbar, Ross N. P. Cahill, H.E. Hansson and Lauritz Bredrup Dahl. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.